The proposed sale is small and originates from an option exercise, likely for tax or diversification purposes. Given the company's pre-revenue biotech status and the officer's role, the filing alone does not suggest a material negative signal. Monitor for the actual Form 4 filing to confirm execution.
Price Chart
Executive Summary
Tiago Girao, an officer of Immunovant, filed a Form 144 indicating intent to sell 10,000 shares (~$384,640 at filing) via a registered option exercise. The filing represents advance notice of a planned sale, not a completed transaction, and the amount is modest relative to the $7.9B market cap.
Key Facts
- Officer Tiago Girao filed Form 144 on June 26, 2026
- Proposed sale of 10,000 shares of common stock
- Estimated aggregate value: $384,640
- Shares to be sold originated from exercise of options under a registered plan
- The proposed sale is not yet completed — Form 144 indicates intent
Financial Impact
10,000 shares at ~$38.46/share, ~$384,640 aggregate value (0.005% of market cap)
Risk Factors
- Pre-revenue biotech with binary pipeline catalysts; insider selling near data readouts could raise concerns
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-006530 |
| Document: 0001950047-26-006530-index.html | 0001950047-26-006530 |
| Document: 0001950047-26-006530.txt | 0001950047-26-006530 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 6, 2026 11w ago | 8-K | $39.74 $39.12 | ▲ +1.56% | ▲ +2.16% | $27.68 (+30.35%) |
Jul 24, 2026 13w ago | Insider Cluster | $40.09 $43.32 | ▲ +8.06% | ▲ +4.76% | $27.68 (−30.96%) |
Jun 26, 2026 17w ago | Insider Cluster | $38.51 $39.41 | ▲ +2.34% | ▲ +2.62% | $27.68 (−28.12%) |
Jun 26, 2026 17w ago | Insider Cluster | $38.51 $39.41 | ▲ +2.34% | ▲ +2.62% | $27.68 (−28.12%) |
Jun 26, 2026 17w ago | 144 | $38.51 $39.41 | ▲ +2.34% | ▲ +2.62% | $27.68 (−28.12%) |
Jun 26, 2026 17w ago | 144 | $38.51 $39.41 | ▲ +2.34% | ▲ +2.62% | $27.68 (−28.12%) |
Jun 15, 2026 18w ago | 144 | $33.61 $38.77 | ▲ +15.35% | ▲ +15.15% | $27.68 (−17.64%) |
May 28, 2026 21w ago | 144 | $33.30 $38.51 | ▲ +15.65% | ▲ +17.44% | $27.68 (−16.88%) |
May 20, 2026 22w ago | 8-K | $35.56 $35.34 | ▼ −0.62% | ▼ −1.36% | $27.68 (−22.16%) |
May 20, 2026 22w ago | Press Release | $35.56 $35.34 | ▼ −0.62% | ▼ −1.36% | $27.68 (−22.16%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers